Diagnostic Tests for Mild Cognitive Impairment and Prodromal Dementia
Meta-analysis by A. Breton, D. Casey and N. Arnaoutoglou
Mild Cognitive Impairment and Dementia Tests Systemic Review and Meta-Analysis
A recent meta-analysis study that investigated the use of cognitive tests in mild cognitive impairment identified the most sensitive/specialized tests.
This study performed by Breton Alexandre, Casey Daniel and Arnaoutoglou Nikitas has shown that clinicians should avoid using the Mini-Mental State Examination (MMSE) for the diagnosis of dementia.
The suggested primary tests are the MoCA and the ACE-R in a tertiary setting. In addition, the study concluded that a new to the public test named Memory Alteration test is the most sensitive test for the early stages of dementia.
The main reason behind this argument is that the well-known MMSE does not properly diagnose about one out of ten patients in the early stages of the disease.
The dementia tests proposed for general practitioners are: MoCA ACE-R or ACE-III (>20 minutes) and the shortest ones Memory Alteration Test (M@T) and QMCI (both under 5 min to perform).
Read more about our study at:
https://onlinelibrary.wiley.com/doi/abs/10.1002/gps.5016
or
https://www.ncbi.nlm.nih.gov/pubmed/30370616
- PMID: 30370616
- DOI:10.1002/gps.5016
- This Study was presented at the RCPsych Annual conference of Faculty of OldAge Psychiatry Annual Conference 13-15 March 2019 in Nottingham, UK.
